��������

Anna Dodds joined Neuraptive Therapeutics in June of 2019 and is Senior Research Associate in Clinial Operations. She is responsible for facilitating and directing all aspects of the physician surgical training programs as it relates to the procedural aspects of NTX-001. Anna is a leader in Neuraptive’s non-clinical programmatic efforts from the earliest stage of development to final hypothesis supporting data for Regulatory submissions. She is a champion of the product and is eager to see NTX-001 change the lives of patients.

Anna earned her Bachelor of Science degree in Chemical and Biological Engineering with a minor in Biomedical Engineering in 2019 from Colorado State University.